Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

ASH congress news: New genetic outcome predictor for infant leukaemia

ASH congress news: New genetic outcome predictor for infant leukaemia

Steady decline in European cancer mortality

Steady decline in European cancer mortality

Colorectal: Cetuximab plus chemo shrinks tumours and helps surgery

Colorectal: Cetuximab plus chemo shrinks tumours and helps surgery

Drug shrinks lung cancer tumours in mice

Drug shrinks lung cancer tumours in mice

Drug regimen shows promising results for treating advanced biliary-tract cancers

Drug regimen shows promising results for treating advanced biliary-tract cancers

Metformin out of context: an example of paradigm shift in the drug development process?

Metformin out of context: an example of paradigm shift in the drug development process?

Optimal techniques more efficient than conventional histopathology at identifying pre-cancerous polyps

Optimal techniques more efficient than conventional histopathology at identifying pre-cancerous polyps

Erythropoiesis-stimulating agents associated with higher risk of venous thromboembolism

Erythropoiesis-stimulating agents associated with higher risk of venous thromboembolism

Addition of capecitabine improves recurrence-free survival in breast cancer patients

Addition of capecitabine improves recurrence-free survival in breast cancer patients

Cetuximab continues to increase survival in patients with head and neck cancer for up to 5 years

Cetuximab continues to increase survival in patients with head and neck cancer for up to 5 years

More from ecancer